| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |